日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ERBB3 blockade sensitizes hepatocellular carcinoma to regorafenib after first-line tyrosine kinase inhibitor resistance by inhibiting HIF1A-ABCB1 signaling

ERBB3阻断通过抑制HIF1A-ABCB1信号通路,使一线酪氨酸激酶抑制剂耐药的肝细胞癌对瑞戈非尼敏感。

Tao, Baorui; Yi, Chenhe; Zhang, Bo; Geng, Yan; Gu, Yinchen; Sun, Rongquan; Wang, Xiangyu; Lin, Jing; Chen, Jinhong

Oligodendrocyte-secreted ERBB3 Mediates the Competitive Uptake of Copper Ions by Tumor Cells to Promote Brain Metastasis in Lung Cancer

少突胶质细胞分泌的ERBB3介导肿瘤细胞对铜离子的竞争性摄取,从而促进肺癌脑转移

Yang, Yuechao; Gao, Yang; Cui, Huanhuan; Li, Sen; Qi, Zhe; Wang, Zhisu; Li, Deheng; Chen, Lei; Feng, Mingtao; Wu, Xiaojun; Chen, Xin; Hao, Bin; Zhou, Changshuai; Li, Liangdong; Cao, Yiqun

Loss of ErbB3 redirects Integrin β1 from early endosomal recycling to secretion in extracellular vesicles

ErbB3 的缺失使整合素 β1 从早期内体循环转向分泌到细胞外囊泡中。

Dorival Mendes Rodrigues-Junior # ,Ana Rosa Sáez-Ibáñez # ,Takeshi Terabayashi ,Nina Daubel ,Taija Mäkinen ,Olof Idevall-Hagren ,Aristidis Moustakas ,Ingvar Ferby

Non-HLA Risk Loci ERBB3/IKZF4 and ERBB2/IKZF3/GSDMB/ORMDL3 Interact to Influence Progression of Autoimmunity in Relatives of T1D Patients

非HLA风险位点ERBB3/IKZF4和ERBB2/IKZF3/GSDMB/ORMDL3相互作用影响1型糖尿病患者亲属自身免疫性疾病的进展

Mertens, Ina M; Keymeulen, Bart; Gorus, Frans K; Van De Casteele, Mark

An integrated microfluidic system for automatic and self-validated analysis of cervical extracellular vesicle markers PD-L1 and ERBB3

用于自动和自验证分析宫颈细胞外囊泡标志物PD-L1和ERBB3的集成微流控系统

Lu, Yunxing; Qin, Han; Zhang, Wenjing; Shi, Qiang; Hui, Jianan; Wu, Zhenhua; Song, Yiman; Yang, Xiaoyue

N-phenylquinazolin-4-amine-based EGFR TKIs suppress pulmonary fibrosis by modulating the EGFR/ERBB3 axis in epithelial-macrophage interaction.

基于 N-苯基喹唑啉-4-胺的 EGFR TKIs 通过调节上皮-巨噬细胞相互作用中的 EGFR/ERBB3 轴来抑制肺纤维化。

Kim Ji-Hee, Choi Seo-Hyun, Nam Jae-Kyung, Park Min-Sik, Seo Haeng Ran, Choi Inhee, Lee Hae-June, Cho Jaeho, Lee Jeeyong, Lee Yoon-Jin

PTEN loss and ERBB2/ERBB3-mediated AKT reactivation drive resistance to MET inhibition in MET-amplified hepatocellular carcinoma

PTEN缺失和ERBB2/ERBB3介导的AKT再激活导致MET扩增型肝细胞癌对MET抑制剂产生耐药性。

Qian, Ruolan; Guo, Yuchen; Hu, Xiaolin; Ling, Jing; Geng, Haigang; Ye, Qiaoqiao; Zhang, Linmeng; Zhan, Shujie; Liao, Long; Ge, Yang; Zheng, Quan; Cao, Ying

PCNP promotes hepatocellular carcinoma progression by upregulating UHRF2 to activate ErbB3/Ras/Raf pathway.

PCNP通过上调UHRF2激活ErbB3/Ras/Raf通路,促进肝细胞癌的进展。

Diverse ERBB2/ERBB3 Activating Alterations and Coalterations Have Implications for HER2/3-Targeted Therapies across Solid Tumors

多种ERBB2/ERBB3激活改变和联合改变对实体瘤HER2/3靶向治疗具有重要意义

Liu, Dazhi; Jee, Justin; Drilon, Alexander; Heilmann, Andreas M; Allen, Justin M; Schrock, Alexa B; Keller-Evans, Rachel B; Li, Bob T

Single-cell profiling of ERBB family receptors identifies ERBB3 as a key regulator in head and neck squamous cell carcinoma progression

单细胞分析ERBB家族受体发现ERBB3是头颈部鳞状细胞癌进展的关键调控因子

Yuling Luo #,Youwei Li #,Shuqin Liu,Renmei Hu,Jinzhi Wu